Massive IPO Stock Alert: Lucy Scientific (NASDAQ:LSDI) Announces It’s $7.5M IPO

Lucy Scientific manufactures therapeutic psychedelics and made a huge announcement, we will get...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

QSI the good stock to buy? Important new development...
UPDATE: ISPC Gains 200%, We Called It!
Ocular Therapeutix OCUL Stock Price is down 21%, can...

Lucy Scientific manufactures therapeutic psychedelics and made a huge announcement, we will get to that soon.

The Global Psychedelics Market Is Expected To Reach almost $100 BN By 2029 Full Article

That is larger than the cannabis market segment, without a market leader.

Lucy Scientific has made some serious steps toward possibly dominating the market.

This is exciting investors, it is a second chance at the cannabis boom but bigger.

In case, you need a reminder of how crazy that ride was, the market grew by 250% in less than a year.

UPDATE:

Breaking News:

March 21, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or “The Company”) [NASDAQ:LSDI], an early-stage psychedelics manufacturing company, announced that it has entered into a definitive asset purchase agreement with Wesana Health Holdings Inc. (“Wesana”).

Lucy has agreed to acquire intellectual property and related assets for Wesana’s psilocybin and cannabidiol (CBD) combination investigational therapy, SANA-013, and Wesana’s supply of psilocybin which is sufficient to complete all near-term clinical studies.  The aggregate consideration comprises 1,000,000 shares of common stock and $570,000 in cash. The shares will be subject to a lock-up agreement whereby half of the shares will be released 9 months from closing, and other half will be released 14 months from closing. The transaction is also subject to Wesana’s shareholder approval and is expected to close in Q2 2023.

Small Cap Exclusive has built a reputation of uncovering stocks with massive upside potential, concentrating on IPOs and we have uncovered some interesting data on LSDI.

Our research reports have uncovered some of the largest breakout stock alerts year after year.

LSDI may even be the best yet. So put us to the test and put it on your watchlist.

We stand by our alerts, our 2023 alert tracker provides transparency. Click HERE

Small Cap Exclusive’s much anticipated research report on Lucy Scientific (NASDAQ:LSDI) is found below.

Top 3 catalysts that could send LSDI up 127%++ in the next month:

#1 The Chart

#2 IPOs Offer A Significant Upside Potential

#3 The Market Could Be As Big As Coffee

Lucy’s Other Explosive Catalysts

  • Recent news has has not been covered by major financial news outlets, creating a unique opportunity.
  • Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin. Press Release
  • Files Amendment with Health Canada to Expand its List of Controlled Substances to Include Cocaine and Heroin Press Release

Why do we consider Lucy Scientific as a contender for the best stock of 2023?

Large announcements in the drug world is turning heads on Wall Street and it feels like 2017’s green boom with cannabis.

Wait until you see what we have uncovered!

Major Psychedelic Announcements:

2019: May 9th

Denver, Colorado became the first city in the United States to decriminalize the cultivation, possession and use of psilocybin mushrooms.

2019: June 5th

Oakland California decriminalized the cultivation, possession and use of plants or fungi containing psychedelic compounds including DMT, ibogaine, mescaline and psilocybin.

2019: September 4th

Johns Hopkins launched the Center for Psychedelic and Consciousness Research.  The center’s director, Roland Griffiths, said that researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, learning, memory, and biological markers of health.

2019: November 22nd

The Food and Drug Administration granted Breakthrough Therapy designation to the Usona Institute for its psilocybin therapy for major depressive disorder.  Usona’s phase 2 clinical trials will include 80 volunteers at seven sites around the U.S. 

2020: October 22nd

In Vancouver, Canada Numinus Wellness Inc. harvested the first legal flush of psilocybin mushrooms by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s License.

2021: October 18th

Johns Hopkins Medicine was awarded a $3.9 million grant by the National Institutes of Health (NIH) for clinical research on psilocybin-assisted psychotherapy to treat tobacco addiction.

Let’s take a closer look at Lucy LSDI.

2023: March 23

Announced today the launch of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.

The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy’.

Lucy Scientific Discovery Company Summary

Company Name: Lucy Scientific Discovery

Ticker: LSDI

Exchange: NASDAQ

Website: https://www.lucyscientific.com/

Lucy’s Company Summary:

Lucy Scientific Discovery Inc. [NASDAQ:LSDI] an early-stage psychedelics manufacturing company that is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines industry.

Lucy maintains a Controlled Drugs and Substances Dealer’s License under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), more commonly known as a Dealer’s License, that was issued to Lucy by Health Canada’s Office of Controlled Substances.

This Dealer’s License authorizes the Company to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.

Before we review #1 Catalyst, their technology suite, let’s review how the catalysts above could generate parabolic growth.

As mentioned above, Lucy Scientific Discovery trades on the NASDAQ as an IPO, which indicates the incredible upside potential.

#1 The Chart

The chart has clearly broken out and is creating a bullish trend line. Start your research now before it is too late, just like the green boom.

#2 IPOs Offer A Significant Upside Potential

Facebook META acted the same way as most IPOs with hype. They get overbought, they pull back and then run like mad!

Lucy is following that same pattern and we believe it has created a bottom and has broken out clearly in the above image.

Look at what Motley Fool wrote about the massive opportunity FB provided, “The stock was offered at $38 per share via the IPO. Let’s assume you bought 132 shares for a total of $5,016 on May 18, 2012, and held all the way through to today. At today’s price of around $191 per share, those 132 shares would be worth $25,212, resulting in a market-beating five-bagger.”

Just like the cannabis boom, and Facebooks IPO, traders are being handed another possible monumental opportunity.

#3 The Market Could Be As Big As Coffee

The global mushroom market size was valued at USD 50.3 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030. The increasing vegan population demanding a protein-rich diet around the globe is expected to be a key driver for the market over the forecast period. Mushrooms are considered a superfood owing to their nutritional contents. Mushrooms are packed with four key nutrients namely selenium, vitamin D, glutathione, and ergothioneine. These nutrients help mitigate oxidative stress and prevent or decrease the risk of chronic conditions such as cancer, heart disease, and dementia. Moreover, it offers a strong natural umami flavor, allowing consumers to reduce salt proportion in mushroom meals by 30-40%, thereby benefitting health.

The U.S. was the second-largest producer accounting for approximately 375 million kg in the year 2019. The production in the country is declining since 2017 and has declined by 11% from 2017 to 2019. Whereas the demand from end-users is growing, which has resulted in an increase in the prices by 6% in 2017-18 and by 3% in 2018-19. The U.S. government is continuously increasing import duties, which is also contributing to the higher prices of mushrooms. Mushroom is one of the protein-rich vegan sources as it offers nearly 3.3 g of protein per 100 g of serving. Meat has been a key source of protein in the western diet; thus, the population adopting a vegan diet is anticipated to prefer protein-rich vegan products to fulfill their daily protein requirements.

Condensed Disclaimer

Small Cap Exclusive is owned and operated by King Tide Media, LLC, which is a US based corporation & has been compensated $350,000 from Lucy Scientific Discovery Inc. for profiling LSDI. We own ZERO shares in LSDI.

FULL DISCLAIMER

Stay in the lopp :

Guess Who Picked Taser International Inc. (NA...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Taser International Inc. (NASDAQ:TASR) reported that Villere St Denis J
Enzolytics Inc (ENZC) Stock Gains Further Mom...

If you are into micro-cap stocks then you might have noticed that Enzolytics Inc (OTCMKTS:ENZC) has emerged as one of the major movers

Here's Who Just Picked Up Genvec Inc. (NASDAQ...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Genvec Inc. (NASDAQ:GNVC) reported that Mmcap International Inc. Spc has

related post

Skip to content